Skip to main content

UBS Group AG

Position in ATNM — Actinium Pharmaceuticals, Inc.

CIK 1610520 ZURICH, V8

Position in ATNM

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$14,544
+$14,415 QoQ
Shares Held
14,618
+15127.1% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ATNM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. ATNM ranks #450 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ATNM

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $14,544 14,618
2025-12-31 $129 96
2025-09-30 $23,321 14,576
2025-06-30 $35,825 25,590
2025-03-31 $637,778 396,136
2024-12-31 $111,908 88,816
2024-09-30 $69,520 36,979
2024-06-30 $168,526 22,774
2024-03-31 $217,016 27,716
2023-12-31 $151,165 29,757
2023-09-30 $72,004 12,163
2023-03-31 $25,552 2,704
2022-12-31 $34,452 3,235
2022-09-30 $13,549 1,836
2022-06-30 $173 36
2021-12-31 $300 50
2021-09-30 $1,329 150
2021-06-30 $22,487 2,843
2021-03-31 $1,143 150